{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:25:47Z","timestamp":1787873147494,"version":"build-2784847793"},"reference-count":68,"publisher":"Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glob Health Sci Pract"],"published-print":{"date-parts":[[2022,10,31]]},"DOI":"10.9745\/ghsp-d-21-00789","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T22:15:27Z","timestamp":1665094527000},"page":"e2100789","source":"Crossref","is-referenced-by-count":11,"title":["What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device"],"prefix":"10.9745","volume":"10","author":[{"given":"Kate H.","family":"Rademacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha","family":"Sripipatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendal","family":"Danna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Sitrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Brunie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayode","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francia","family":"Rasoanirina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Ramarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pfitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Menotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hazelwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Adindu","family":"Nwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Saidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raveena","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Taiwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Chidanyika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gathari","family":"Ndirangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Chantale","family":"Lepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Homan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmumin","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vivalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laneta J.","family":"Dorflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4690","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"2022110209414055000_10.5.e2100789.1","unstructured":"World Health Organization (WHO). WHO Statement on Levonorgestrel-Releasing Intrauterine Device Nomenclature. WHO; 2021. Accessed August 7, 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240021730"},{"key":"2022110209414055000_10.5.e2100789.2","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-18-00383"},{"key":"2022110209414055000_10.5.e2100789.3","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-15-00178"},{"key":"2022110209414055000_10.5.e2100789.4","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-15-00330"},{"key":"2022110209414055000_10.5.e2100789.5","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-15-00327"},{"key":"2022110209414055000_10.5.e2100789.6","unstructured":"Hatcher RA Kowal D Nelson AL . Contraceptive Technology. 21st ed. Ayer Company Publishers, Inc.; 2018."},{"key":"2022110209414055000_10.5.e2100789.7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821188ad"},{"key":"2022110209414055000_10.5.e2100789.8","doi-asserted-by":"publisher","DOI":"10.1363\/43e5217"},{"key":"2022110209414055000_10.5.e2100789.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2019.12.002"},{"key":"2022110209414055000_10.5.e2100789.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.05.005"},{"key":"2022110209414055000_10.5.e2100789.11","doi-asserted-by":"publisher","DOI":"10.2147\/oajc.s85565"},{"key":"2022110209414055000_10.5.e2100789.12","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-17-00396"},{"key":"2022110209414055000_10.5.e2100789.13","unstructured":"FHI 360, Society for Family Health Zambia (SFH), Population Services International (PSI), WCG Cares. Final Report: Market Assessment for Potential Introduction of a New Hormonal IUCD in Zambia. FHI 360\/SFH\/PSI\/WCG Cares; 2016. Accessed August 15, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/Provider-Perspectives\/resource\/Zambia-Hormonal-IUS-Market-Assessment"},{"key":"2022110209414055000_10.5.e2100789.14","unstructured":"Danna K Jackson A Mann C Harris D . Lessons Learned from the Introduction of the Levonorgestrel Intrauterine System (LNG-IUS) in Zambia and Madagascar. WCG Cares\/Population Services International; 2019. Accessed August 25, 2022. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/Current\/EECO%3A-Lessons-Learned-from-the-Introduction-of-the-LNG-IUS-in-Zambia-and-Madagascar"},{"key":"2022110209414055000_10.5.e2100789.15","unstructured":"Routes2Results, Population Services International. Understanding the market potential of the IUS in Kenya and Nigeria. Final webinar. February 27, 2019. Accessed September 1, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/Potential\/LEAP%3A-Hormonal-IUS-Market-Research-Qualitative-Findings-in-Kenya-and-Nigeria"},{"key":"2022110209414055000_10.5.e2100789.16","unstructured":"Routes2Results, Population Services International. Understanding end-user (women) and healthcare provider (HCP) preference for the IUS contraceptive in Nigeria and Kenya. Dissemination report. November 2019. Accessed September 1, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/Potential\/LEAP%3A-Hormonal-IUS-Market-Research-Quantitative-Findings-in-Kenya-and-Nigeria"},{"key":"2022110209414055000_10.5.e2100789.17","unstructured":"Hormonal IUD Access Group. Hormonal IUD Access Group updates for key stakeholders. January 2022. Accessed August 7, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/Coordination-%26-Advocacy\/Global\/Hormonal-IUD-Access-Group-Updates-for-Key-Stakeholders"},{"key":"2022110209414055000_10.5.e2100789.18","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-18-00242"},{"key":"2022110209414055000_10.5.e2100789.19","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.13135.1"},{"key":"2022110209414055000_10.5.e2100789.20","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-20-00556"},{"key":"2022110209414055000_10.5.e2100789.21","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00318-1"},{"key":"2022110209414055000_10.5.e2100789.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257769"},{"key":"2022110209414055000_10.5.e2100789.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01745-7"},{"key":"2022110209414055000_10.5.e2100789.24","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-021-01300-x"},{"key":"2022110209414055000_10.5.e2100789.25","unstructured":"Rademacher K . Applying the power of partnership to evaluation of a long-acting contraceptive. R&E Search for Evidence blog. May 8, 2017. Accessed March 15, 2022. https:\/\/researchforevidence.fhi360.org\/applying-the-power-of-partnership-to-evaluation-of-a-long-acting-contraceptive"},{"key":"2022110209414055000_10.5.e2100789.26","unstructured":"Community of Practice on Method Choice, Hormonal IUD Access Group. Hormonal IUS updates: new insights and steps toward scale. Presented at: Global Technical Consultation \u2013 Day 1; June 25, 2020. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/resource\/Hormonal-IUD-Updates%3A-June-2020-Technical-Consultation-%E2%80%93-Day-1"},{"key":"2022110209414055000_10.5.e2100789.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.02.024"},{"key":"2022110209414055000_10.5.e2100789.28","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13716"},{"key":"2022110209414055000_10.5.e2100789.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003110"},{"key":"2022110209414055000_10.5.e2100789.30","unstructured":"Mirena. Prescribing information. Bayer HealthCare Pharmaceuticals Inc.; 2009. Accessed November 15, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021225s027lbl.pdf"},{"key":"2022110209414055000_10.5.e2100789.31","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)90109-0"},{"key":"2022110209414055000_10.5.e2100789.32","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(91)90078-T"},{"key":"2022110209414055000_10.5.e2100789.33","doi-asserted-by":"publisher","DOI":"10.2147\/OAJC.S85755"},{"key":"2022110209414055000_10.5.e2100789.34","unstructured":"About Mirena. Bayer. Accessed September 30, 2021. https:\/\/www.mirenahcp.com\/"},{"key":"2022110209414055000_10.5.e2100789.35","unstructured":"About us. International Contraceptive Access Foundation. Accessed August 26, 2022. https:\/\/ica-foundation.org\/ica-foundation\/about-us\/"},{"key":"2022110209414055000_10.5.e2100789.36","unstructured":"About the projects. International Contraceptive Access Foundation. Accessed August 26, 2022. https:\/\/ica-foundation.org\/projects\/about-the-projects\/"},{"key":"2022110209414055000_10.5.e2100789.37"},{"key":"2022110209414055000_10.5.e2100789.38","unstructured":"Haelle T . Could the most effective birth control soon become the cheapest? Forbes Magazine. May 2, 2016. Accessed September 15, 2021. https:\/\/www.forbes.com\/sites\/tarahaelle\/2016\/05\/02\/could-the-most-effective-birth-control-soon-become-the-cheapest\/?sh=1141a6f96853"},{"key":"2022110209414055000_10.5.e2100789.39","unstructured":"The Avibela Project. Medicines360. Accessed September 15, 2021. https:\/\/www.medicines360.org\/avibela-project\/"},{"key":"2022110209414055000_10.5.e2100789.40","unstructured":"FDA approves Medicines360\u2019s LILETTA\u00ae (levonorgestrel-releasing intrauterine system) 52 mg to prevent pregnancy for up to six years. Press release. Medicines360. October 28, 2019. Accessed September 15, 2021. https:\/\/www.medicines360.org\/2019\/10\/28\/fda-approves-medicines360s-liletta\/"},{"key":"2022110209414055000_10.5.e2100789.41","unstructured":"Nanda G Brennan C Brunie A . Adolescent girls\u2019 and young women\u2019s perspectives on the LNG-IUS in Nigeria. Final report presentation. May 2020. Accessed September 15, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/Youth\/LEAP%3A-Adolescent-Girls\u2019-and-Young-Womens\u2019-Perspectives-on-the-LNG-IUS-in-Nigeria"},{"key":"2022110209414055000_10.5.e2100789.42","unstructured":"Nanda G Brennan C Brunie A . Adolescent girls\u2019 and young women\u2019s perspectives on the LNG-IUS in Zambia. Final report presentation. May 2020. Accessed September 15, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/Youth\/LEAP%3A-Adolescent-Girls\u2019-and-Young-Womens\u2019-Perspectives-on-the-LNG-IUS-in-Zambia"},{"key":"2022110209414055000_10.5.e2100789.43","unstructured":"Homan R Rademacher KH Stankevitz K Brunie A . Cost-effectiveness of Including the Hormonal IUD in the Contraceptive Method Mix in Nigeria and Zambia: Summary of Results. Final brief. FHI 360\/Population Services International; 2021. Accessed December 3, 2021. https:\/\/www.hormonaliud.org\/ourlibrary\/Cost-Effectiveness\/resource\/Cost-effectiveness-analysis-of-including-hormonal-IUD-in-the-contraceptive-method-mix-in-Nigeria-and-Zambia%3A-Summary-of-results"},{"key":"2022110209414055000_10.5.e2100789.44","unstructured":"Community of Practice on Method Choice, Hormonal IUD Access Group. Hormonal IUS updates: new insights and steps toward scale. Presented at: Global Technical Consultation \u2013 Day 2; June 26, 2020. https:\/\/www.hormonaliud.org\/ourlibrary\/User-Perspectives\/resource\/Hormonal-IUD-Updates%3A-June-2020-Technical-Consultation-%E2%80%93-Day-2"},{"key":"2022110209414055000_10.5.e2100789.45","unstructured":"Guttmacher Institute. Adding It Up: Investing in Contraception and Maternal and Newborn Health in Nigeria. Guttmacher Institute; 2019. Accessed August 26, 2022. https:\/\/www.guttmacher.org\/fact-sheet\/adding-it-up-contraception-mnh-nigeria"},{"key":"2022110209414055000_10.5.e2100789.46","unstructured":"Nigeria National Population Commission (NPC). Nigeria Demographic and Health Survey 2018. NPC\/ICF; 2019. Accessed August 26, 2022. https:\/\/dhsprogram.com\/pubs\/pdf\/FR359\/FR359.pdf"},{"key":"2022110209414055000_10.5.e2100789.47","unstructured":"Commitment maker since 2012: Nigeria. FP2020. Accessed August 15, 2021. https:\/\/www.familyplanning2020.org\/nigeria"},{"key":"2022110209414055000_10.5.e2100789.48","unstructured":"Nigeria. Federal Ministry of Health (FMOH). Second National Strategic Health Development Plan: 2018\u20132022. FMOH; 2018. Accessed September 15, 2021. https:\/\/www.health.gov.ng\/doc\/NSHDP%20II%20Final.pdf"},{"key":"2022110209414055000_10.5.e2100789.49","unstructured":"Nigeria. Federal Ministry of Health (FMOH). Nigeria National Family Planning Blueprint 2020\u20132024. FMOH; 2020. Accessed September 15, 2021. https:\/\/www.familyplanning2020.org\/sites\/default\/files\/Final-2020-Blueprint.pdf"},{"key":"2022110209414055000_10.5.e2100789.50","unstructured":"Projects: Nigeria. International Contraceptive Access Foundation. Accessed July 15, 2021. https:\/\/ica-foundation.org\/projects\/about-the-projects\/nigeria\/"},{"key":"2022110209414055000_10.5.e2100789.51","unstructured":"Commitment maker since 2015: Madagascar. FP2020. Accessed August 15, 2021. https:\/\/fp2030.org\/madagascar"},{"key":"2022110209414055000_10.5.e2100789.52","unstructured":"Cain D . New Catalytic Opportunity Fund to support hormonal IUD introduction activities. January 19, 2021. Updated April 12, 2021. Accessed August 15, 2021. https:\/\/www.hormonaliud.org\/post\/new-catalytic-opportunity-fund-to-support-hormonal-ius-introduction-activities"},{"key":"2022110209414055000_10.5.e2100789.53","unstructured":"Introduction of long-acting family planning method to USAID and UNFPA product catalogs. FP2030. June 28, 2021. Accessed September 1, 2021. https:\/\/familyplanning2020.org\/news\/introduction-long-acting-family-planning-method-usaid-and-unfpa-product-catalogs"},{"key":"2022110209414055000_10.5.e2100789.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.01.003"},{"key":"2022110209414055000_10.5.e2100789.55","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-19-00383"},{"key":"2022110209414055000_10.5.e2100789.56","unstructured":"The Access Collaborative: putting self-injectable contraception within reach. PATH. November 2, 2020. Accessed September 1, 2021. https:\/\/www.path.org\/articles\/dmpa-sc-collaborative\/"},{"key":"2022110209414055000_10.5.e2100789.57","unstructured":"PATH, Population Services International, FHI 360, Clinton Health Access Initiative, Population Council, WCG Cares. The highs, lows, and squishy middle of product introduction. Presented at: Global Health Science and Practice Technical Exchange; April 21\u201324, 2021. https:\/\/globalhealthxchange.com"},{"key":"2022110209414055000_10.5.e2100789.58","unstructured":"Shaping Equitable Market Access (SEMA) for Reproductive Health. Accessed September 1, 2021. https:\/\/www.semareprohealth.org\/"},{"key":"2022110209414055000_10.5.e2100789.59","unstructured":"USAID Center for Accelerating Innovation and Impact (CII). Healthy Markets for Global Health: A Market Shaping Primer. CII; 2014. Accessed August 15, 2021. https:\/\/www.usaid.gov\/sites\/default\/files\/documents\/1864\/healthymarkets_primer.pdf"},{"key":"2022110209414055000_10.5.e2100789.60","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-17-00250"},{"key":"2022110209414055000_10.5.e2100789.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2013.03.001"},{"key":"2022110209414055000_10.5.e2100789.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.01.009"},{"key":"2022110209414055000_10.5.e2100789.63","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2018.1499892"},{"key":"2022110209414055000_10.5.e2100789.64","unstructured":"Sedgh G Ashford LS Hussain R . Unmet Need for Contraception in Developing Countries: Examining Women\u2019s Reasons for Not Using a Method. Guttmacher Institute; 2016. Accessed August 30, 2021. http:\/\/www.guttmacher.org\/report\/unmet-need-for-contraception-in-developing-countries"},{"key":"2022110209414055000_10.5.e2100789.65","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-018-0561-0"},{"key":"2022110209414055000_10.5.e2100789.66","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-18-00093"},{"key":"2022110209414055000_10.5.e2100789.67","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.13609.1"},{"key":"2022110209414055000_10.5.e2100789.68","unstructured":"Hubacher D . Clinical trial with the levonorgestrel intrauterine system to measure changes in hemoglobin and serum ferritin among anemic women in Kenya. NIH RePORTER. Project number: 1R01HD100497-01A1. Posted July 21, 2020. Accessed August 26, 2022. https:\/\/reporter.nih.gov\/project-details\/10050175"}],"container-title":["Global Health: Science and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9745\/GHSP-D-21-00789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:43:08Z","timestamp":1667407388000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ghspjournal.org\/lookup\/doi\/10.9745\/GHSP-D-21-00789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,31]]},"published-print":{"date-parts":[[2022,10,31]]}},"alternative-id":["10.9745\/GHSP-D-21-00789"],"URL":"https:\/\/doi.org\/10.9745\/ghsp-d-21-00789","relation":{},"ISSN":["2169-575X"],"issn-type":[{"value":"2169-575X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]}}}